Recent Comments
- Charles Carroll on A food-borne illness mystery and what is wrong with current medical schools
- Is Italian flour healthier than American? | Quality of Life Clinic on Celiac disease is not reduced by breast feeding or delaying the introduction of gluten
- LB on The final House report on COVID
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (26,505)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (18,733)
- The Healthcare Channel hits 10 (16,447)
- New treatment paradigm for C. Diff colitis (16,409)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,555)
- How the FDA regulates compounding pharmacies (15,550)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (15,444)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (12,049)
- The new CDC guidelines for prescribing opioid pain pills (11,162)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (10,973)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Generics
Steven E. Greer, MD on OANN discussing virus therapies
April 16, 2020
Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)
Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.
Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease
Leave a comment
Federal Court of Appeals Rules that FDA Overstepped by Restricting Ivermectin Use
September 2, 2023- by Steven E. Greer, MD
Posted in - Generics, - Pharma, CDC, Congress, FDA
Leave a comment
Ivermectin works against COVID in double blind, randomized, controlled trial
May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.
The FDA pathway for biosimilar drug approvals
March 26, 2015- Interviewed by Steven E. Greer,
Posted in - Biotech, - Generics, FDA
Leave a comment
How to beat the virus with early treatment
July 22, 2021- by Steven E. Greer, MD I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus
India, Mexico, and El Salvador distribute ivermectin to citizens in free COVID kits
January 20, 2022- by Steven E. Greer, MD As all hospitals in the U.S. refuse to administer lifesaving early treatments for the SARS-CoV-2 coronavirus,
Sen. Ron Johnson on the need for early treatment of the Wuhan coronavirus
December 13, 2020- by Steven E. Greer, MD This is straight from my book, Tony’s Virus, chapters 8 and chapter 10.
The Year in Review: 2018
December 29, 2018- by Steven E. Greer, MD The biggest stories this year related
The super shady methods of pricing generic drugs in America: case study- Sildenafil
May 15, 2016- by Steven E. Greer, MD The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil)
Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA
Leave a comment
This could be the best interview ever aired on Fox Business
August 15, 2017- by Steven E. Greer, MD Martin Shkreli was on Fox Business today, and the set seemed familiar. Ironically, I was in this same
Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy
Leave a comment
The Biggest Healthcare Stories of 2016
December 26, 2016- by Steven E. Greer, MD for The Healthcare Channel Policy changes dominated the 2016 year in healthcare news. There were few important new drug
Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - The Weekly Summary, CMS, FDA
Leave a comment
The Biggest stories of 2015
December 31, 2015- by Steven E. Nike Roshe Run Femme Greer, MD 2015 was the year of ISIS. The radical jihadist group started the year with an attack in France,
Actavis 1000% drug price hike: a case for healthcare reform
Update September 21, 2015- The Healthcare Channel was the first to report in 2009 on the business strategy of acquiring cheap generic drugs, cornering the market, then raising
Posted in - Biotech, - Generics, - Opinion, - Policy, CMS, Congress, FDA, Infectious disease
Leave a comment